InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

Current share price for GSS : $0.059 0.001 (1.72%)+

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 Application for quotation of securities - GSS 29 Dec 2023 9:53AM $0.435 $0.059 fallen by 86.44%
$13 Genetic Signatures Successfully Completes Placement 29 Dec 2023 9:52AM $0.435 $0.059 fallen by 86.44%
$13 Cleansing Notice 21 Dec 2023 9:49AM $0.440 $0.059 fallen by 86.59%
$13 Proposed issue of securities - GSS 21 Dec 2023 9:49AM $0.440 $0.059 fallen by 86.59%
$13 Capital Raising Presentation 21 Dec 2023 9:49AM $0.440 $0.059 fallen by 86.59%
$13 Genetic Signatures Announces $15.9m Capital Raising 21 Dec 2023 9:48AM $0.440 $0.059 fallen by 86.59%
$13 $6.9m R&D tax incentive received 19 Dec 2023 9:41AM $0.440 $0.059 fallen by 86.59%
$13 Trading Halt 19 Dec 2023 9:25AM $0.440 $0.059 fallen by 86.59%
$13 Initial Director's Interest Notice 4 Dec 2023 4:37PM $0.520 $0.059 fallen by 88.65%
$13 Genetic Signatures Appoints Non-Executive Director 4 Dec 2023 8:23AM $0.540 $0.059 fallen by 89.07%
$13 AGM Results of Meeting 29 Nov 2023 3:50PM $0.515 $0.059 fallen by 88.54%
$13 2023 AGM Chairman's Address and CEO Presentation 29 Nov 2023 8:17AM $0.505 $0.059 fallen by 88.32%
$13 Quarterly update and Appendix 4C 30 Oct 2023 10:01AM $0.500 $0.059 fallen by 88.20%
$13 2023 Notice of Annual General Meeting/Proxy Form 27 Oct 2023 4:05PM $0.500 $0.059 fallen by 88.20%
$13 Investor Presentation - US Commercial Launch 19 Sep 2023 8:29AM $0.500 $0.059 fallen by 88.20%
$13 Change in substantial holding 15 Sep 2023 11:40AM $0.500 $0.059 fallen by 88.20%
$13 Investor Webinar - FY2023 Results and US FDA 510(k) 4 Sep 2023 8:53AM $0.445 $0.059 fallen by 86.74%
$13 510(k) Filing in Preparation for US Commercial Launch 4 Sep 2023 8:41AM $0.445 $0.059 fallen by 86.74%
$13 FDA 510(k) for Gastrointestinal Parasite Kit Submitted 4 Sep 2023 8:20AM $0.445 $0.059 fallen by 86.74%
$13 Appendix 4G and Corporate Governance Statement 31 Aug 2023 10:47AM $0.465 $0.059 fallen by 87.31%
$13 Appendix 4E and Annual Report 31 Aug 2023 10:44AM $0.465 $0.059 fallen by 87.31%
$13 Influenza B Detection Expected to Impact on Quarter Sales 25 Aug 2023 8:46AM $0.490 $0.059 fallen by 87.96%
$13 Quarterly update and Appendix 4C 31 Jul 2023 9:17AM $0.610 $0.059 fallen by 90.33%
$13 CFO/Company Secretary Appointment 16 Jun 2023 8:54AM $0.530 $0.059 fallen by 88.87%
$13 Quarterly update and Appendix 4C 28 Apr 2023 8:59AM $0.765 $0.059 fallen by 92.29%

151 - 175 of 504 results

Page 7 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.